(Q43644050)

25 November 2017

Increased levels of interleukin 5 are associated with the generation of eosinophilia in drug-induced hypersensitivity syndrome (English)

1 reference

25 November 2017

Choquet-Kastylevsky G

1

1 reference

25 November 2017

Intrator L

2

1 reference

25 November 2017

Chenal C

3

1 reference

25 November 2017

Bocquet H

4

1 reference

25 November 2017

Revuz J

5

1 reference

25 November 2017

Roujeau JC

6

1 reference

25 November 2017

language of work or name

English

0 references

publication date

1 December 1998

1 reference

British Journal of Dermatology

25 November 2017

1 reference

25 November 2017

139

1 reference

25 November 2017

6

1 reference

25 November 2017

1026-1032

1 reference

Anticonvulsant hypersensitivity syndrome. In vitro assessment of risk

25 November 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.1998.02559.X

Drug hypersensitivity syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.1998.02559.X

Severe adverse cutaneous reactions to drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.1998.02559.X

The immunobiology of eosinophils

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.1998.02559.X

Secretion of the eosinophil-active cytokines interleukin-5, granulocyte/macrophage colony-stimulating factor and interleukin-3 by bronchoalveolar lavage CD4+ and CD8+ T cell lines in atopic asthmatics, and atopic and non-atopic controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.1998.02559.X

Increased circulating levels of interleukin-5 in a case of steroid-resistant hypereosinophilic syndrome with ileal involvement. Longcope Firm of the Osler Housestaff.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.1998.02559.X

Eosinophils express interleukin 5 and granulocyte macrophage-colony-stimulating factor mRNA at sites of allergic inflammation in asthmatics

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.1998.02559.X

Interleukin 5 messenger RNA expression by eosinophils in the intestinal mucosa of patients with coeliac disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.1998.02559.X

Cooperation between interleukin-5 and the chemokine eotaxin to induce eosinophil accumulation in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.1998.02559.X

Human eotaxin is a specific chemoattractant for eosinophil cells and provides a new mechanism to explain tissue eosinophilia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.1998.02559.X

Metabolic predisposition to cutaneous adverse drug reactions. Role in toxic epidermal necrolysis caused by sulfonamides and anticonvulsants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.1998.02559.X

Interferon-alpha treatment of six patients with the idiopathic hypereosinophilic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.1998.02559.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.1998.02559.X

10.1046/J.1365-2133.1998.02559.X

21 January 2018

Identifiers

DOI

1 reference

25 November 2017

1 reference